Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline
Whether you are curious about how to safely combine your current medications or you are looking to start a new chapter with GLP-1 therapy, professional guidance is your most valuable asset
Summary: Electrolytes are important on a GLP-1 because these medications commonly cause gastrointestinal side effects and reduced appetite, leading to fluid and electrolyte losses that can result in potentially serious imbalances affecting cardiac rhythm, muscle function, and kidney health
Use our free BMI calculator and compare with the chart below
This helps to prevent cortisol surges and minimizes the usual slowing of metabolism that comes with repeated dieting efforts
Opt for low-impact exercises that dont put too much stress on your knees
